Prosecution Insights
Last updated: July 17, 2026
Application No. 18/031,480

NON-CURABLE SILICONE COMPOSITION COMPRISING CARBON BLACK

Final Rejection §103§112
Filed
Apr 12, 2023
Priority
Oct 21, 2020 — EU 20203115.9 +1 more
Examiner
SLOAN, LILY KAYOKO
Art Unit
1762
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Momentive Performance Materials GmbH
OA Round
2 (Final)
67%
Grant Probability
Favorable
3-4
OA Rounds
0m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 67% — above average
67%
Career Allowance Rate
40 granted / 60 resolved
+1.7% vs TC avg
Strong +36% interview lift
Without
With
+35.9%
Interview Lift
resolved cases with interview
Typical timeline
3y 2m
Avg Prosecution
27 currently pending
Career history
86
Total Applications
across all art units

Statute-Specific Performance

§103
88.8%
+48.8% vs TC avg
§102
5.9%
-34.1% vs TC avg
§112
2.1%
-37.9% vs TC avg
Black line = Tech Center average estimate • Based on career data from 60 resolved cases

Office Action

§103 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Response to Arguments Applicant’s arguments with respect to claim 1 have been considered but are moot because the new ground of rejection does not rely on any reference applied in the prior rejection of record for any teaching or matter specifically challenged in the argument. A new ground of rejection is made in view of Kayashima US 20160333151 and Smale US 20130172446A1. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1-4, 18, 19, and 21 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 1 states “…the extrusion of one or more polyorganosiloxanes a1) with one or more carbon blacks d) wherein the masterbatch comprises 3 o 25 weight percent based on the total weight of the masterbatch.” It is not clear what component of the masterbatch (a1 or d) is present in the amount of 3-25% based on the total weight of the masterbatch. Additionally the term “o” the meaning of the character “o” in between 3 and 25 isn’t clear. Claims 2-4, 18, 19, and 21 depend from claim 1 and are therefore similarly indefinite. For the purpose of examination on the merits, this phrase will be interpreted as requiring that the masterbatch comprises 3-25 wt% of one or more carbon blacks d), consistent with the Applicant’s description of amended claim 1 in their remarks. Claim Rejections - 35 USC § 103 The text of those sections of Title 35, U.S. Code not included in this action can be found in a prior Office action. Claims 1-2 and 21 are rejected under 35 U.S.C. 103 as being unpatentable over Kayashima US 20160333151. Regarding claim 1 and 2, Kayashima teaches a composition comprising a mercapto functional polysiloxane and a filler (Abstract, Paragraph [0030])). Kayashima also teaches the composition is mixed using an extruder (Paragraph [0045]). Kayashima also teaches that the filler and mercapto functional polysiloxane are mixed together using the extruder (Paragraph [0045]). Kayashima describes this mixture as a masterbatch (Paragraph [0045]). Kayashima teaches a curing agent can be added to the masterbatch (Paragraph [0045]). However, the formation of the masterbatch occurs without the presence of a curing agent which reads on the instant Specification’s definition of the term noncurable (Paragraph [0045]). Kayashima teaches the filler can be carbon black (Paragraph [0018]). It would have been obvious for the filler of Kayashima to be carbon black because it is prima facie obvious to select a known material based on its suitability for its intended use. See MPEP 2144.07.This reads on the claimed carbon black.” Kayashima teaches the composition comprises at least 5 to up to 200 phr filler per 100 parts rubber (Paragraph [0042]) and at least 5 phr mercapto polysiloxane (Paragraph [0043]). This translates to 4.5-65% filler. This overlaps with the claimed range of 3-25% filler. Regarding claim 2, Kayashima teaches the mercapto functional polysiloxane comprises a monovalent organic group which can be an alkenyl group (Paragraph [0032]). It would have been obvious for the monovalent organic group of Kayashima to be the alkenyl group because it is prima facie obvious to select a known material based on its suitability for its intended use. See MPEP 2144.07.This reads on the claimed “unsaturated.” Regarding claim 21, Kayashima is silent on the masterbatch comprising a solvent This reads on the limitations of claim 21. Claims 1, 3-4, and 18-19 are rejected under 35 U.S.C. 103 as being unpatentable over Smale US 20130172446A1. Regarding claims 1 and 4, Smale teaches a masterbatch composition comprising carbon black (Paragraph [0067]). Smale also teaches the masterbatch composition comprises a polymer (10) (Paragraph [0023]). Smale teaches that polymer 10 can be a silicone rubber (Paragraph [0044]). Smale also teaches the composition is extruded (Paragraph [0033]). Smale teaches a curing agent may be added to the masterbatch (Paragraph [0038]). However Smale teaches the formation of the masterbatch occurs without the presence of a curing agent which reads on the instant Specification’s definition of the term noncurable (Paragraph [0022-0033]). Smale also teaches he composition comprises the 10-120 phr filler (Paragraph [0027]). Therefore Smale teaches the composition comprises a ratio of from 10:100 to 120:100 filler to polyorganosiloxane. This corresponds to a range of 0.9-54.5% filler this overlaps with the claimed range of 3-25% filler. This also overlaps with the claimed range of 90:10 to 75:25. Regarding claims 18 and 19, Smale teaches the extruder is a twin screw extruder (Paragraph [0033]). Conclusion THIS ACTION IS MADE FINAL. Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to LILY K SLOAN whose telephone number is (703)756-5875. The examiner can normally be reached Monday-Friday 9:00-5:30 ET. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Robert Jones can be reached at (571) 270-7733. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /LILY K SLOAN/Examiner, Art Unit 1762 /ROBERT S JONES JR/Supervisory Patent Examiner, Art Unit 1762
Read full office action

Prosecution Timeline

Apr 12, 2023
Application Filed
Feb 09, 2026
Non-Final Rejection mailed — §103, §112
May 08, 2026
Response Filed
Jun 03, 2026
Final Rejection mailed — §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12674016
HIGH-SOLIDS CURABLE FILM-FORMING COMPOSITIONS AND METHODS OF IMPROVING APPEARANCE OF COATINGS CONTAINING EFFECT PIGMENTS
2y 6m to grant Granted Jul 07, 2026
Patent 12655278
POLYETHYLENE COMPOSITIONS
4y 4m to grant Granted Jun 16, 2026
Patent 12655333
BONDING METHOD
3y 1m to grant Granted Jun 16, 2026
Patent 12655274
COMPOSITE MATERIAL, APPLICATIONS THEREOF, AND METHOD FOR PRODUCING COMPOSITE MATERIAL
1y 6m to grant Granted Jun 16, 2026
Patent 12644224
INTERNALLY EMULISIFIED POLYURETHANE DISPERSION AND METHOD FOR PREPARING THE SAME
3y 0m to grant Granted Jun 02, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
67%
Grant Probability
99%
With Interview (+35.9%)
3y 2m (~0m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 60 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month